13 Paid Clinical Research Studies in Scottsdale, Arizona

Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds

The study will be a prospective, randomized, multi-center, split-face, controlled, double-blind clinical trial to evaluate the safety and effectiveness of ELLANSÉ®-S for the treatm

📍 Investigate MD — Scottsdale, Arizona

💵 Subjects may receive a retreatment touch up at 4 weeks after retreatment, and if touched up, will have safety visits at

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

The purpose of this study is to test the safety and tolerability of HFB200301 as a single agent and in combination with tislelizumab in patients with advanced cancers. There are tw

📍 Mayo Clinic — Scottsdale, Arizona

💵 During the escalation part, groups of participants will receive increasing doses of HFB200301 as a monotherapy or in com

HIFEM and Radiofrequency for Muscular System Function Improvement

The goal of this clinical trial is to investigate the effect of the BTL-899M device on muscular system function in adult subjects seeking treatment for improving their muscular sys

📍 Royal Spine Surgery — Scottsdale, Arizona

💵 At the last therapy visit, the patients will receive the Subject Satisfaction Questionnaire and Therapy Comfort Question

A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer

To determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT) and recommended Phase 2 dose (RP2D) in patients who receive FF-10832 (Gemcitabine Lipo

📍 Honor Health Research Institute — Scottsdale, Arizona

💵 To determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT) and recommended Phase 2 do

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

This is a phase 2, open-label, randomized, non-comparative clinical trial to evaluate the clinical outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab

📍 Honor Health — Scottsdale, Arizona

💵 Subjects may receive up to 4 prior regimens of combination or single agent systemic treatment for their disease, which m

The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)

The objective for this clinical study is to provide FDA with clinical evidence regarding the effectiveness and safety of the AGBS + moderate intensity lifestyle modification therap

📍 HonorHealth Research Institute — Scottsdale, Arizona

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic sclerosis. The target

📍 Research Site — Scottsdale, Arizona

💵 * Double Blind Treatment Period: Treatment Period when participants will receive once weekly injections of anifrolumab o

REFLECTION: A Clinical Practice Learning Program for Galleri®

REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-b

📍 Vincere Cancer Center — Scottsdale, Arizona

Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients

This phase III trial compares the rate of complications of x-ray therapy versus proton beam radiation therapy after breast conserving surgery or mastectomy in treating patients wit

📍 Mayo Clinic in Arizona — Scottsdale, Arizona

💵 Optionally, patients may receive a concurrent 5-fraction boost of proton beam radiation therapy.

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

The main goal of this trial is to evaluate the efficacy and safety of amlenetug for the treatment of participants with Multiple System Atrophy (MSA).

📍 Mayo Clinic — Scottsdale, Arizona

💵 Participants will receive intravenous infusions approximately every 4 weeks during both the PCP and OLE.

Safety and Efficacy of the BTL-043 and BTL-899 Devices in Alleviating Back Pain

The study will evaluate the clinical efficacy and performance of the BTL-043 and BTL-899 devices for alleviating back pain. It is a prospective, multi-center, open-label, single-ar

📍 Royal Spine Surgery — Scottsdale, Arizona

💵 During each treatment visit, subjects will receive treatments with both study devices, BTL-043 and BTL-899, consecutivel

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

The purpose of this study is to evaluate the efficacy and safety of efgartigimod PH20 SC given by a pre-filled syringe in adult patients with ocular myasthenia gravis. The study co

📍 HonorHealth Neurology - Bob Bové Neuroscience Institute — Scottsdale, Arizona

💵 In part A, half of the participants will receive efgartigimod PH20 SC and the other half will receive placebo.

Targeting Inflammation for Endometrial Cancer Prevention

This study examines risk assessment and identifies prevention strategies for endometrial cancer. Collecting samples of blood and urine and risk assessments from patients with benig

📍 Mayo Clinic in Arizona — Scottsdale, Arizona